US-based Rakuten Medical has announced positive interim data from the Phase Ib/II trial of its photoimmunotherapy, ASP-1929, in combination with Merck & Co’s Keytruda (pembrolizumab) in patients with ...

San Diego biotech Aspyrian Therapeutics just raised $40 million, according to a regulatory filing, to pursue a fascinating new way to activate the immune system to kill cancer: Photoimmunotherapy.

A magnifying glass. It indicates, "Click to perform a search". A magnifying glass. It indicates, "Click to perform a search". SAN MATEO, Calif., Oct. 27, 2021 /PRNewswire/ -- Rakuten Medical, Inc.

New York, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Photoimmunotherapy Market - Competition Forecast and ...

The goal of the phase 2 trial is to study the safety and efficacy of ASP-1929, a photoimmunotherapy with fluorescence imaging, in patients with head and neck or skin cancer. A phase 2 clinical trial ...

Please provide your email address to receive an email when new articles are posted on . Researchers at Rush University Medical Center are assessing the safety and efficacy of the experimental ...

Liquid metals are a new type of material with unique properties. Pure gallium (Ga) and Ga-based alloys are one type of liquid metal used for immunotherapy in cancer treatment. The liquid metal ...

When Kerstin Stenson, MD, describes the innovative technique she is helping develop to fight cancer, it seems like she's describing a Tom Clancy military espionage novel. Stenson is treating patients ...

In a recent Light Science & Applications article, researchers addressed a significant challenge in cancer therapy: the immunosuppressive microenvironment and the low immunogenicity of tumor cells, ...

When Kerstin Stenson, MD, describes the innovative technique she is helping develop to fight cancer, it seems like she's describing a Tom Clancy military espionage novel. Stenson is treating patients ...

Scientists at the Institute of Cancer Research in London have developed a new light-activated “photoimmunotherapy” that could help treat brain cancer. The key is a compound that glows under light to ...

When Kerstin Stenson, MD, describes the innovative technique she is helping develop to fight cancer, it seems like she's describing a Tom Clancy military espionage novel. Stenson is treating patients ...